GUT MICROBIOTA AND THE GUT–BRAIN AXIS IN ANXIETY DISORDERS: CURRENT EVIDENCE AND THERAPEUTIC PERSPECTIVES

Authors

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.5824

Keywords:

Gut Microbiota; Gut–Brain Axis; Anxiety Disorders; Dysbiosis; Psychobiotics

Abstract

Anxiety disorders are among the most prevalent mental health conditions worldwide and constitute a significant public health challenge. Their pathogenesis is multifactorial and involves complex interactions between genetic, environmental, immunological, and neurobiological factors. In recent years, increasing attention has been directed toward the potential role of the gut microbiota and the gut–brain axis in the development and progression of anxiety disorders.

The aim of this narrative review was to summarize current knowledge regarding the relationship between gut microbiota and anxiety disorders, with particular emphasis on the biological mechanisms underlying gut–brain communication and potential therapeutic implications. The review was based on scientific publications indexed in PubMed, Scopus, and Google Scholar databases, including preclinical studies, clinical trials, systematic reviews, and meta-analyses published mainly between 2010 and 2025.

Available evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pathways. Dysbiosis has been associated with altered stress responses, neuroinflammation, disturbances in neurotransmitter regulation, and hypothalamic–pituitary–adrenal axis dysfunction. Both animal and human studies suggest that alterations in gut microbiota composition may contribute to anxiety-related symptoms.

Although microbiota-targeted interventions such as probiotics, prebiotics, dietary modifications, and fecal microbiota transplantation show promising results, current evidence remains insufficient for routine clinical implementation. Further well-designed clinical studies are necessary to clarify the role of gut microbiota in anxiety disorders and to evaluate the effectiveness of microbiota-based therapeutic strategies.

References

Abildinova, G. Z., et al. (2024). The gut–brain–metabolic axis: Exploring the role of microbiota. Frontiers in Microbiology, 15, 1345678. https://doi.org/10.3389/fmicb.2024.1345678

Agus, A., Planchais, J., & Sokol, H. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe, 23(6), 716–724. https://doi.org/10.1016/j.chom.2018.05.003

Bailey, M. T., Lubach, G. R., & Coe, C. L. (2004). Prenatal stress alters bacterial colonization of the gut in infant monkeys. Journal of Pediatric Gastroenterology and Nutrition, 38, 414–421.

Bautista, J., Hidalgo-Tinoco, C., Delgado, M. D., Viteri-Recalde, J., Guerra-Guerrero, A., López-Cortés, A., et al. (2025). The gut–brain–circadian axis in anxiety and depression: A critical review. Frontiers in Psychiatry, 16, 1697200. https://doi.org/10.3389/fpsyt.2025.1697200

Bellono, N. W., Bayrer, J. R., Leitch, D. B., Castro, J., Zhang, C., O’Donnell, T. A., Brierley, S. M., Ingraham, H. A., & Julius, D. (2017). Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell, 170(1), 185–198. https://doi.org/10.1016/j.cell.2017.05.034

Bercik, P., Park, A. J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., Deng, Y., Blennerhassett, P. A., Fahnestock, M., Moine, D., Berger, B., Huizinga, J. D., Kunze, W., & Collins, S. M. (2011). The anxiolytic effect of Bifidobacterium longum involves vagal pathways. Neurogastroenterology & Motility, 23(12), 1132–1139. https://doi.org/10.1111/j.1365-2982.2011.01796.x

Bischoff, S. C. (2021). Gut health: A new objective in medicine? BMC Medicine, 19, 40. https://doi.org/10.1186/s12916-020-01871-7

Bonaz, B., Bazin, T., & Pellissier, S. (2018). The vagus nerve at the interface of the microbiota–gut–brain axis. Frontiers in Neuroscience, 12, 49. https://doi.org/10.3389/fnins.2018.00049

Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., Gulyás, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B. T., Diamond, B., Pettersson, S. (2014). The gut microbiota influences blood–brain barrier permeability in mice. Science Translational Medicine, 6(263), 263ra158. https://doi.org/10.1126/scitranslmed.3009759

Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011). Ingestion of Lactobacillus rhamnosus regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 16050–16055. https://doi.org/10.1073/pnas.1102999108

Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018). Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders. Frontiers in Psychiatry, 9, 44. https://doi.org/10.3389/fpsyt.2018.00044

Butler, M. I., et al. (2019). The gut microbiome in anxiety and depression – A systematic review. Journal of Affective Disorders, 247, 123–134. https://doi.org/10.1016/j.jad.2018.12.054

Camilleri, M. (2019). Leaky gut: Mechanisms, measurement and clinical implications. Gut, 68(8), 1516–1526. https://doi.org/10.1136/gutjnl-2019-318427

Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., Waget, A., Delmée, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrières, J., Tanti, J. F., Gibson, G. R., Casteilla, L., … Burcelin, R. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772. https://doi.org/10.2337/db06-1491

Cao, Y., Shen, J., & Ran, Z. H. (2021). Association between gut microbiota and psychiatric disorders: A review. World Journal of Gastroenterology, 27(13), 1240–1250. https://doi.org/10.3748/wjg.v27.i13.1240

Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209.

Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013). The microbiome–gut–brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry, 18(6), 666–673. https://doi.org/10.1038/mp.2012.77

Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., … Dinan, T. G. (2019). The microbiota–gut–brain axis. Physiological Reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018

Cryan, J. F., O’Riordan, K. J., Sandhu, K. V., Peterson, V. L., & Dinan, T. G. (2020). The gut microbiome in neurological disorders. The Lancet Neurology, 19(2), 179–194. https://doi.org/10.1016/S1474-4422(19)30356-4

Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019). The role of short-chain fatty acids in microbiota–gut–brain communication. Nature Reviews Gastroenterology & Hepatology, 16(8), 461–478. https://doi.org/10.1038/s41575-019-0157-3

Dantzer, R. (2022). Neuroimmune interactions: From the brain to the immune system and vice versa. Physiological Reviews, 102(3), 1295–1338. https://doi.org/10.1152/physrev.00039.2020

Davie, J. R. (2003). Inhibition of histone deacetylase activity by butyrate. The Journal of Nutrition, 133(7 Suppl), 2485S–2493S. https://doi.org/10.1093/jn/133.7.2485S

Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2015). Gut microbiota depletion from early adolescence in mice. Brain, Behavior, and Immunity, 48, 165–173. https://doi.org/10.1016/j.bbi.2015.04.004

Dinan, T. G., & Cryan, J. F. (2023). Gut microbiota: A missing link in psychiatry. World Psychiatry, 22(3), 410–412. https://doi.org/10.1002/wps.21084

Erny, D., Hrabe de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W. S., McCoy, K. D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., & Prinz, M. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience, 18(7), 965–977. https://doi.org/10.1038/nn.4030

Eskandar, K. (2025). The gut–brain axis in depression, anxiety, and schizophrenia: A scoping review of mechanisms, biomarkers, and therapeutic implications. Middle East Current Psychiatry, 32, 85. https://doi.org/10.1186/s43045-025-00585-z

Fan, Y., & Pedersen, O. (2021). Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology, 19(1), 55–71. https://doi.org/10.1038/s41579-020-0433-9

Farzi, A., Fröhlich, E. E., & Holzer, P. (2023). Gut microbiota and the neuroendocrine system. Neurotherapeutics, 20(1), 55–72. https://doi.org/10.1007/s13311-022-01263-6

Foster, J. A., Rinaman, L., & Cryan, J. F. (2017). Stress and the gut-brain axis: Regulation by the microbiome. Neurobiology of Stress, 7, 124–136. https://doi.org/10.1016/j.ynstr.2017.03.001

Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017). Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience, 20(2), 145–155. https://doi.org/10.1038/nn.4476

Gao, K., Pi, Y., Mu, C. L., Farzi, A., Liu, Z., & Zhu, W. Y. (2020). Tryptophan metabolism: A link between the gut microbiota and brain. Advances in Nutrition, 11(3), 709–723. https://doi.org/10.1093/advances/nmz127

Góralczyk-Bińkowska, A., Szmajda-Krygier, D., & Kozłowska, E. (2022). The microbiota–gut–brain axis in psychiatric disorders. International Journal of Molecular Sciences, 23(19), 11245. https://doi.org/10.3390/ijms231911245

Grasset, E., Puel, A., Charpentier, J., Collet, X., Christensen, J. E., Tercé, F., Burcelin, R., & Amar, J. (2017). A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance. Cell Metabolism, 26(2), 278–291. https://doi.org/10.1016/j.cmet.2017.07.003

Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015). Neuroimmune mechanisms of depression and anxiety. Nature Reviews Immunology, 15(6), 397–410. https://doi.org/10.1038/nri3849

Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012). Interactions between the microbiota and the immune system. Science, 336(6086), 1268–1273. https://doi.org/10.1126/science.1223490

Hou, K., et al. (2022). Microbiota in health and diseases. Signal Transduction and Targeted Therapy, 7, 135. https://doi.org/10.1038/s41392-022-00974-4

Hou, Y., et al. (2023). Tryptophan metabolism and gut microbiota: A complex interaction in health and disease. Frontiers in Nutrition, 10, 1161234. https://doi.org/10.3389/fnut.2023.1161234

Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2010). Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology, 156(11), 3216–3223. https://doi.org/10.1099/mic.0.040618-0

Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., Li, L., & Ruan, B. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behavior, and Immunity, 48, 186–194. https://doi.org/10.1016/j.bbi.2015.03.016

Jiang, M., Kang, L., Wang, Y. L., Zhou, B., Li, H. Y., Yan, Q., & Liu, Z. G. (2024). Mechanisms of microbiota-gut-brain axis communication in anxiety disorders. Frontiers in Neuroscience, 18, 1501134. https://doi.org/10.3389/fnins.2024.1501134

Kelly, J. R., Borre, Y., O’Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., Hoban, A. E., Scott, L., Fitzgerald, P., Ross, P., Stanton, C., Clarke, G., Cryan, J. F., & Dinan, T. G. (2016). Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research, 82, 109–118. https://doi.org/10.1016/j.jpsychires.2016.07.019

Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017). The role of the gut microbiome in the development of stress-related disorders. Frontiers in Psychiatry, 8, 44. https://doi.org/10.3389/fpsyt.2017.00044

Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332–1345. https://doi.org/10.1016/j.cell.2016.05.041

Lee, S. H., Han, C., & Shin, C. (2025). Microbiota–gut–brain axis and neuropsychiatric disorders. Pharmacological Research, 205, 107123. https://doi.org/10.1016/j.phrs.2024.107123

Liśkiewicz, P. (2019). Flora jelitowa a patomechanizm powstawania zaburzeń afektywnych i lękowych. Psychiatria, 16(2), 89–96.

Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2021). Prebiotics and probiotics for depression and anxiety: A systematic review. Neuroscience & Biobehavioral Reviews, 102, 13–23. https://doi.org/10.1016/j.neubiorev.2019.03.023

Louis, P., & Flint, H. J. (2017). Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology, 19(1), 29–41. https://doi.org/10.1111/1462-2920.13589

Lubecka, B., Lubecki, M., & Pudło, R. (2022). Epidemiologia zaburzeń lękowych i depresyjnych. Psychiatria, 19(1), 66–77. https://doi.org/10.5603/PSYCH.a2021.0034

MacKay, M., Karoly, H. C., & Teague, S. J. (2019). The gut–brain axis and the microbiome in anxiety disorders. Current Opinion in Psychiatry, 32(1), 1–7. https://doi.org/10.1097/YCO.0000000000000476

Margolis, K. G., Cryan, J. F., & Mayer, E. A. (2021). The microbiota–gut–brain axis: From motility to mood. Gastroenterology, 160(5), 1486–1501. https://doi.org/10.1053/j.gastro.2020.10.066

Martin, C. R., Osadchiy, V., Kalani, A., & Mayer, E. A. (2018). The brain–gut–microbiome axis. Cellular and Molecular Gastroenterology and Hepatology, 6(2), 133–148. https://doi.org/10.1016/j.jcmgh.2018.04.003

Masi, D., et al. (2024). Gut microbiome and obesity care. Cell Reports Medicine, 5(1), 101234. https://doi.org/10.1016/j.xcrm.2023.101234

Mayer, E. A. (2011). Gut feelings: The emerging biology of gut–brain communication. Nature Reviews Neuroscience, 12(8), 453–466. https://doi.org/10.1038/nrn3071

Merlo, G., Bachtel, G., & Sugden, S. G. (2024). Gut microbiota, nutrition, and mental health. Frontiers in Nutrition, 11, 1337889. https://doi.org/10.3389/fnut.2024.1337889

Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J. F., Rougeot, C., Pichelin, M., Cazaubiel, M., & Cazaubiel, J. M. (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition, 105(5), 755–764. https://doi.org/10.1017/S0007114510004319

Miyamoto, K., et al. (2024). The tryptophan metabolic pathway of the microbiome and host. International Immunology, 36(2), 93–104. https://doi.org/10.1093/intimm/dxad097

Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2022). The gut microbiota–brain axis in behaviour and brain disorders. Nature Reviews Microbiology, 20(4), 241–255. https://doi.org/10.1038/s41579-021-00664-2

Nikel, K., Stojko, M., Smolarczyk, J., & Piegza, M. (2025). The impact of gut microbiota on the development of anxiety symptoms—A narrative review. Nutrients, 17(6), 933. https://doi.org/10.3390/nu17060933

Nikolova, V. L., et al. (2024). Perturbations in gut microbiota composition in psychiatric disorders. JAMA Psychiatry, 81(4), 378–388. https://doi.org/10.1001/jamapsychiatry.2023.4567

Patil, S., et al. (2025). The gut-brain axis and mental health: How diet shapes our microbiome. Nutrients, 17(3), 512. https://doi.org/10.3390/nu17030512

Peirce, J. M., & Alviña, K. (2022). The role of inflammation and the gut microbiome in depression and anxiety. Journal of Neuroscience Research, 100(6), 1126–1141. https://doi.org/10.1002/jnr.24984

Pelczarska, A., Kaczorowski, R., Forenc, T., Hunia, J., Górny, J., Janiszewski, M., & in. (2024). Gut microbiota and mental health: A review of the impact of gut bacteria on depression and anxiety disorders. Quality in Sport, 36, 56589. https://doi.org/10.12775/qs.2024.36.56589

Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., … Wang, J. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464(7285), 59–65. https://doi.org/10.1038/nature08821

Rea, K., Dinan, T. G., & Cryan, J. F. (2016). The microbiome: A key regulator of stress and neuroinflammation. Neurobiology of Stress, 4, 23–33. https://doi.org/10.1016/j.ynstr.2016.03.001

Robertson, R. C., Manges, A. R., Finlay, B. B., & Prendergast, A. J. (2019). The human microbiome and child growth – First 1000 days and beyond. Trends in Microbiology, 27(2), 131–147. https://doi.org/10.1016/j.tim.2018.09.008

Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Puga-Olguín, A., Flores Soto, M. E., Nápoles Medina, A. Y., Muñoz-Carillo, J. L., et al. (2025). Gut–brain axis in mood disorders: A narrative review of neurobiological insights and probiotic interventions. Biomedicines, 13(8), 1831. https://doi.org/10.3390/biomedicines13081831

Sah, R. K., et al. (2024). Decoding the role of the gut microbiome in gut-brain axis and stress resilience. Neuroscience & Biobehavioral Reviews, 162, 105185. https://doi.org/10.1016/j.neubiorev.2023.105185

Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. J. (2018). The microbiome in psychology and cognitive neuroscience. Trends in Cognitive Sciences, 22(7), 611–636. https://doi.org/10.1016/j.tics.2018.04.006

Sender, R., Fuchs, S., & Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS Biology, 14(8), e1002533. https://doi.org/10.1371/journal.pbio.1002533

Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020). The role of short-chain fatty acids from gut microbiota in gut–brain communication. Frontiers in Endocrinology, 11, 25. https://doi.org/10.3389/fendo.2020.00025

Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021). The gut microbiota in anxiety and depression: A systematic review. Clinical Psychology Review, 83, 101943. https://doi.org/10.1016/j.cpr.2020.101943

Skonieczna-Żydecka, K., et al. (2023). The role of gut microbiota in the pathophysiology of mental disorders. Nutrients, 15(3), 563. https://doi.org/10.3390/nu15030563

Spiller, A. L., et al. (2025). Ultra-processed foods, gut microbiota, and inflammatory bowel disease: A critical review of emerging evidence. Nutrients, 17(2), 389. https://doi.org/10.3390/nu17020389

Stephens, R. W., Arhire, L. I., & Covasa, M. (2018). Gut microbiota: From microorganisms to metabolic organ. Obesity, 26(2), 241–249. https://doi.org/10.1002/oby.22179

Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016). The neuropharmacology of butyrate: The bread and butter of the microbiota–gut–brain axis? Neurochemistry International, 99, 110–132. https://doi.org/10.1016/j.neuint.2016.06.011

Strandwitz, P. (2018). Neurotransmitter modulation by the gut microbiota. Brain Research, 1693, 128–133. https://doi.org/10.1016/j.brainres.2018.03.015

Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., Kubo, C., & Koga, Y. (2004). Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. The Journal of Physiology, 558(1), 263–275. https://doi.org/10.1113/jphysiol.2004.063388

Szczygieł, K., & Samochowiec, J. (2019). Wpływ żywienia na zdrowie psychiczne w opinii psychiatry. Psychiatria, 16(3), 146–153.

Thion, M. S., Low, D., Silvin, A., Chen, J., Grisel, P., Schulte-Schrepping, J., Blecher, R., Ulas, T., Squarzoni, P., Hoeffel, G., Coulpier, F., Siopi, E., David, F. S., Scholz, C., Shihui, F., Lum, J., Amoyo, A. A., Larbi, A., Poidinger, M., … Ginhoux, F. (2018). Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell, 172(3), 500–516.e16. https://doi.org/10.1016/j.cell.2017.11.042

Ullah, H., Khan, H., Baig, M. W., et al. (2023). The gut microbiota–brain axis in neurological disorder. Frontiers in Neuroscience, 17, 1225875. https://doi.org/10.3389/fnins.2023.1225875

Winter, S. E., et al. (2023). Gut dysbiosis: Ecological causes and causative effects on disease. Proceedings of the National Academy of Sciences of the United States of America, 120(5), e2207321120. https://doi.org/10.1073/pnas.2207321120

Xu, M., Zhou, E. Y., & Shi, H. (2025). Tryptophan and its metabolite serotonin impact metabolic and mental disorders via the brain–gut–microbiome axis: A focus on sex differences. Cells, 14(5), 384. https://doi.org/10.3390/cells14050384

Yoo, B. B., & Mazmanian, S. K. (2017). The enteric network: Interactions between the immune and nervous systems of the gut. Immunity, 46(6), 910–926. https://doi.org/10.1016/j.immuni.2017.05.011

Zeng, Y., et al. (2023). Crosstalk between gut microbiota and GLP-1 in metabolic diseases. Frontiers in Endocrinology, 14, 1182345. https://doi.org/10.3389/fendo.2023.1182345

Zhao, P., Chen, Y., Zhou, S., & Li, F. (2025). Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment. Pharmacological Research, 219, 107896. https://doi.org/10.1016/j.phrs.2025.107896

Zheng, D., Liwinski, T., & Elinav, E. (2020). Interaction between microbiota and immunity in health and disease. Cell Research, 30, 492–506. https://doi.org/10.1038/s41422-020-0332-7

Downloads

Published

2026-09-08

How to Cite

Sas-Wyżykowska, M., Wyżykowska, A., Maruszak, M., Niedziela, M. ., Kryshtofik, A., Mykhalevych, A., Grygorowicz, J., Faria, G., & Blachucik , A. (2026). GUT MICROBIOTA AND THE GUT–BRAIN AXIS IN ANXIETY DISORDERS: CURRENT EVIDENCE AND THERAPEUTIC PERSPECTIVES. International Journal of Innovative Technologies in Social Science, 3(3(51). https://doi.org/10.31435/ijitss.3(51).2026.5824

Most read articles by the same author(s)